Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Secukinumab Efficacy Without the Initial Loading Dose in Patients With Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03828643
Recruitment Status : Completed
First Posted : February 4, 2019
Last Update Posted : April 16, 2019
Sponsor:
Information provided by (Responsible Party):
Paolo Gisondi, Universita di Verona

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 12, 2019
  Actual Study Completion Date : April 12, 2019